TSLP激活树突状细胞介导Trm细胞异常分化、活化在特应性皮炎发生发展中的作用及机制研究
批准号:
82103738
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
廖威
依托单位:
学科分类:
皮肤免疫性疾病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
廖威
中文摘要
特应性皮炎(Atopic Dermatitis, AD)是一种以T细胞介导为主的复发性慢性炎症性皮肤病。然而,循环中T细胞的异常不能完全阐明AD的发生和迁延不愈。组织原位型记忆T细胞(Trm)是新近发现的T细胞亚型,参与多种炎症性皮肤病。我们前期工作发现AD患者皮损中Trm数量增多;再者,我们亦观察到OVA诱导AD小鼠模型中皮损中Trm表达水平增高,提示Trm细胞可能参与AD的发生发展。已有研究发现AD异常高表达TSLP且TSLP可以直接被树突状细胞提呈,病毒感染模型提示不同亚型的树突状细胞能不同程度影响Trm细胞的启动、分化和活化,然而AD中树突状细胞如何激活Trm细胞暂无报道。因此我们假设:TSLP调控树突状细胞,介导Trm细胞分化活化进而参与AD的发生与复发。本课题拟从体内体外实验探究AD中Trm细胞异常分化活化的具体机制,为寻找AD治疗新靶点提供理论依据。
英文摘要
Atopic Dermatitis (AD) is a recurrent chronic inflammatory skin disease mediated by T cells. However, these abnormal circulating T cells can’t fully explain the relapse of AD. Tissue resident memory T cells (Trm cells) are a newly identified T cells subtype, which involved in various inflammatory skin diseases. Our previous work found that the increased number of Trm cells in AD patients’ skin lesions; in addition, we also observed that increased Trm cells in skin lesions of OVA-induced AD mouse models, suggesting that Trm cells may participate in the development of AD. Studies have proved abnormal expression level of TSLP in AD and TSLP can be directly presented by dendritic cells. Virus infection models suggest that different subtypes of dendritic cells can affect the initiation, differentiation and activation of Trm cells. However, the mechanism behind dendritic cells activate Trm cells in AD has not been reported yet. Therefore, we hypothesize that TSLP primes dendritic cells, mediates the differentiation and activation of Trm cells, which participate in the occurrence and relapse of AD. This project intends to explore the specific mechanism of abnormal differentiation and activation of Trm cells in AD by in vivo and in vitro experiments, and provide a theoretical basis for finding novel therapeutic targets for AD.
特应性皮炎(AD)是一种以T细胞介导为主的复发性慢性炎症性皮肤病,然而循环中T细胞的异常不能完全阐明AD的发生和迁延不愈。组织原位型记忆T细胞(Trm)是新近发现的T细胞亚型,参与多种炎症性皮肤病,其在AD中的作用及机制尚无报道。我们前期工作发现AD患者皮损中Trm数量增多。本项目在此基础上,进一步研究发现卡泊三醇诱导特应性皮炎小鼠皮损中Trm数量增多,提示Trm细胞参与AD的发生发展。在单细胞测序结果中,我们目前发现IL-13可能参与AD的发生与发展。在小鼠模型中进一步验证卡泊三醇诱导的AD小鼠模型,并同时分别予以FTY-720(阻断淋巴细胞从淋巴结迁移进组织)及相应的对照处理小鼠,予以FTY-720处理组Trm细胞数量减少,炎症因子减轻从而皮损炎症浸润减轻,皮损厚度减轻。通过体内外实验我们提出Trm细胞可能通过调控一系列炎症因子的表达参与AD皮损的产生和发展。为阐明AD发病机制提供了重要的理论和实验依据,为AD治疗提供新的靶点。
国内基金
海外基金